Clustering of Haemostatic Risk Factors with FXIIIVal34Leu in Patients with Myocardial Infarction

• References

• 1 Schwarz ML, Pizzo SV, Hill RL, McKee PA. Human factor XIII from plasma and platelets. Molecular weights, subunit structure, proteolytic activation, and cross-linking of fibrinogen and fibrin. J Biol Chem 1973; 248: 1359-407.
• 2 Kohler HP, Stickland MH, Ossei-Gerning N, Carter A, Mikkola H, Grant PJ. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 1998; 79: 8-13.
• 3 Jansson JH, Olofsson BO, Nilson TK. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease: a 7 year follow-up. Circulation 1993; 88: 2030-4.
• 4 Kelleher CC, Mitropoulos KA, Imeson J, Meade TW, Martin JC, Reeves BEA, Hughes LO. Hageman factor and risk of myocardial infarction in middle-aged men. Atherosclerosis 1992; 97: 67-73.
• 5 Kohler HP, Carter AM, Stickland MH, Grant PJ. Levels of activated FXII in survivors of myocardial infarction. Association with circulating risk factors and extent of coronary artery disease. Thromb Haemost 1998; 79: 14-8.